|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.40 PLN | +1.47% |
|
+1.30% | -8.66% |
| 27/05 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 15/05 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Projected Income Statement: Scope Fluidics S.A.
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Net sales 1 | - | 0.1 | 2.5 | - |
| Change | - | - | 2,400% | - |
| EBITDA 1 | - | -37.4 | -65.3 | -81.1 |
| Change | - | - | -74.6% | -24.2% |
| EBIT 1 | - | -47.28 | -68.6 | -84.6 |
| Change | - | - | -45.09% | -23.32% |
| Interest Paid | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | -46.05 | -67.2 | 494.5 |
| Change | - | - | -45.92% | 835.86% |
| Net income 1 | 65.42 | -46.36 | -54.4 | 400.5 |
| Change | - | -170.87% | -17.33% | 836.21% |
| Announcement Date | 28/4/25 | 25/3/26 | - | - |
1PLN in Million
Estimates
Forecast Balance Sheet: Scope Fluidics S.A.
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Net Debt 1 | - | -107 | -97.1 | -494 |
| Change | - | - | 9.25% | -408.75% |
| Announcement Date | 28/4/25 | 25/3/26 | - | - |
1PLN in Million
Estimates
Cash Flow Forecast: Scope Fluidics S.A.
| Fiscal Period: December | 2025 | 2026 | 2027 |
|---|---|---|---|
| CAPEX 1 | 4.7 | 6.9 | 7.1 |
| Change | - | 46.81% | 2.9% |
| Free Cash Flow (FCF) 1 | - | - | - |
| Change | - | - | - |
| Announcement Date | - | - | - |
1PLN in Million
Estimates
Forecast Financial Ratios: Scope Fluidics S.A.
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
Profitability | ||||
| EBITDA Margin (%) | - | -5,342.86% | -2,612% | - |
| EBIT Margin (%) | - | -47,282% | -2,744% | - |
| EBT Margin (%) | - | -46,053% | -2,688% | - |
| Net margin (%) | - | -46,364% | -2,176% | - |
| FCF margin (%) | - | - | - | - |
| FCF / Net Income (%) | - | - | - | - |
Profitability | ||||
| ROA | - | -25.14% | -32.1% | 116.2% |
| ROE | - | -30.03% | -40.3% | 129.9% |
Financial Health | ||||
| Leverage (Debt/EBITDA) | - | - | - | - |
| Debt / Free cash flow | - | - | - | - |
Capital Intensity | ||||
| CAPEX / Current Assets (%) | - | 671.43% | 276% | - |
| CAPEX / EBITDA (%) | - | -12.57% | -10.57% | -8.75% |
| CAPEX / FCF (%) | - | - | - | - |
Items per share | ||||
| Cash flow per share 1 | - | - | - | - |
| Change | - | - | - | - |
| Dividend per Share 1 | - | - | - | - |
| Change | - | - | - | - |
| Book Value Per Share 1 | - | 39.3 | 34.1 | 160.5 |
| Change | - | - | -13.23% | 370.67% |
| EPS 1 | 24 | -14.64 | -17.2 | 126.4 |
| Change | - | -161% | -19.44% | 834.88% |
| Nbr of stocks (in thousands) | 2,726 | 3,168 | 3,168 | 3,168 |
| Announcement Date | 28/4/25 | 25/3/26 | - | - |
1PLN
Estimates
| 2025 | 2026 * | |
|---|---|---|
| P/E Ratio | -9.3x | -7.23x |
| PBR | 3.17x | 3.65x |
| EV / Sales | 4,315x | 119x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
124.40PLN
Average target price
198.20PLN
Spread / Average Target
+59.32%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCP Stock
- Financials Scope Fluidics S.A.
Select your edition
All financial news and data tailored to specific country editions
